| 货号 | 物种 | 产品描述 | 蛋白结构 | 纯度 | 活性 |
|---|---|---|---|---|---|
| OX0-H82F7 |
 Human |
Biotinylated Human OX40 Protein, Fc,Avitag |
 |
  |
  |
| OX0-H5224 |
Human |
Human OX40 / TNFRSF4 / CD134 Protein, His Tag (MALS verified) |
 |
 |
 |
| OX0-H5255 |
Human |
Human TNFRSF4 /OX40 /CD134 Protein, With C-Fc Tag |
 |
 |
 |
| OX0-M5228 |
 Mouse |
Mouse OX40 / TNFRSF4 / CD134 Protein, His Tag |
 |
 |
 |
| OX0-M5259 |
Mouse |
Mouse TNFRSF4 /OX40/CD134 Protein,C-Fc Tag |
 |
 |
 |
| OX0-C5220 |
 Rhesus macaque |
Rhesus macaque OX40 / TNFRSF4 / CD134 Protein, His Tag |
 |
 |
 |
| OX0-C5251 |
Rhesus macaque |
Rhesus Macaque TNFRSF4 /OX40/CD134 Protein,C-Fc Tag |
 |
 |
 |
| OX0-R5253 |
 Rat |
Rat OX40 / TNFRSF4 / CD134 Protein, Fc Tag |
 |
 |
|
| OX0-R5254 |
 Rabbit |
Rabbit OX40 / TNFRSF4 / CD134 Protein, Fc Tag |
 |
 |
|
| TN4-H82E4 |
Human |
Biotinylated Human OX40 / TNFRSF4 / CD134 Protein, Avitag™,His Tag (MALS verified) (recommended for biopanning) |
 |
 |
 |
| OX0-M522b |
Marmoset |
Marmoset OX40 / TNFRSF4 / CD134 Protein, His Tag |
 |
 |
 |
| OX0-H5252 |
Human |
Human OX40 / TNFRSF4 / CD134 Protein, Mouse IgG2a Fc Tag, low endotoxin |
 |
 |
 |
| OX0-M82E5 |
Mouse |
Biotinylated Mouse OX40 / TNFRSF4 / CD134 Protein, His,Avitag |
 |
 |
 |
| 英文名称 | 研发代码 | 研发阶段 | 公司 | 适应症 | 临床试验 |
|---|---|---|---|---|---|
| INCAGN-1949 | INCAGN-1949 | 临床二期 | Agenus, 路德维格癌症研究所, Incyte | 尿生殖系统癌症, 肾细胞癌, 实体瘤 | 详情 |
| SHR-1806 | SHR-1806 | 临床申请 | 上海恒瑞, 江苏恒瑞, 苏州盛迪亚 | 不明 | |
| YH-002 | YH-002 | 临床一期 | 祐和 | 晚期实体瘤 | 详情 |
| BGB-A445 | BGB-A445 | 临床一期 | 百济神州 | 实体瘤 | 详情 |
| Efizonerimod alfa | MEDI-6383,MEDI6383 | 临床一期 | MedImmune | 实体瘤 | 详情 |
| GSK3174998 | GSK-3174998; GSK 3174998; GSK3174998 | 临床二期 | 葛兰素史克 | 实体瘤, 头颈癌 | 详情 |
| FS-120 | FS-120 | 临床申请 | F-star | 癌症 | |
| PF-04518600 | PF-04518600; PF-8600 | 临床二期 | 辉瑞 | 肾细胞癌, 乳腺癌, 实体瘤 | 详情 |
| SL-279252 | SL-279252; TAK-252 | 临床一期 | Shattuck Labs | 胃腺癌, 非小细胞肺癌, 弥漫大B细胞淋巴瘤, 肾细胞癌, 尿路上皮癌, 实体瘤, 头颈部鳞状细胞癌, 霍奇金淋巴瘤, 胃食管交界腺癌, 黑色素瘤 | |
| INBRX-106 | INBRX-106 | 临床一期 | Inhibrx | 实体瘤 | 详情 |
| BMS-986178 | BMS-986178 | 临床二期 | 百时美施贵宝 | 实体瘤 | 详情 |
| Recombinant human anti-OX40 monoclonal antibody (Livzon Group) | 临床一期 | 丽珠医药集团 | 癌症 | ||
| MEDI-6469 | MEDI-6469 | 临床二期 | AgonOx, Providence Cancer Center, MedImmune | 弥漫大B细胞淋巴瘤, 前列腺癌, 乳腺癌, 结肠直肠癌, 头颈癌, 黑色素瘤 | 详情 |
| Recombinant human anti-OX40 monoclonal antibody (Innovent Biologics) | IBI-101,IBI101 | 临床一期 | 信达生物制药(苏州) | 癌症 | 详情 |
| KHK-4083 | KHK-4083 | 临床二期 | 协和发酵麒麟 | 溃疡性结肠炎 | 详情 |
| ATOR-1015 | ATOR-1015; ADC-1015 | 临床一期 | Alligator Bioscience | 实体瘤 | 详情 |
| Tavolimab | MEDI-0562,MEDI0562 | 临床二期 | MedImmune | 卵巢癌 | 详情 |
| GBR-830 | GBR-830 | 临床二期 | Glenmark Pharmaceuticals | 特应性皮炎 | 详情 |
| Vonlerolizumab | RO-7021608; MOXR-0916; RG-7888 | 临床二期 | 基因泰克 | 实体瘤 | 详情 |
